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ABSTRACT: The pars tuberalis (PT) of the pituitary gland expresses a high density of melatonin (MEL) 
receptors and is believed to regulate seasonal physiology by decoding changes in nocturnal melatonin 
secretion. Circadian clock genes are known to be expressed in the PT in response to the decline (Per1) 
and onset (Cry1) of MEL secretion, but to date little is known of other molecular changes in this key 
MEL target site. To identify transcriptional pathways that may be involved in the diurnal and 
photoperiod-transduction mechanism, we performed a whole genome transcriptome analysis using PT 
RNA isolated from sheep culled at three time points over the 24h cycle under either long or short 
photoperiods. Our results reveal 153 transcripts where expression differs between photoperiods at the 
light/dark transition and 54 transcripts where expression level was more globally altered by photoperiod 
(all time points combined). Cry1 induction at night was associated with up-regulation of genes coding for 
NeuroD1 (Neurogenic differentiation factor 1), Pbef/Nampt, (nicotinamide phosphoribosyltransferase), 
Hif1α (hypoxia-inducible factor-1alpha) and Kcnq5 (K+ channel) and down-regulation of Rorβ, a key 
clock gene regulator. Using in situ hybridization, we confirmed day-night differences in expression for 
Pbef/Nampt, NeuroD1 and Rorβ in the PT. Treatment of sheep with MEL increased PT expression for 
Cry1, Pbef/ Nampt, NeuroD1 and Hif1α, but not Kcnq5. Our data thus reveal a cluster of Cry1 associated 
genes which are acutely responsive to MEL and novel transcriptional pathways involved in MEL action 
in the PT.  
 Seasonally breeding animals have to 
anticipate environmental events in order to 
optimize their survival and reproductive success. 
The annual photoperiod cycle provides a critical 
environmental signal, which entrains seasonal 
physiology. Nocturnal secretion of the pineal 
hormone melatonin reflects these seasonal 
changes in photoperiod and thereby provides the 
brain with an internal hormonal representation of 
external photoperiod changes. Seasonal cycles in 
melatonin modulates multiple physiological 
systems including reproduction, food intake, 
adiposity, body temperature regulation and many 
neuroendocrine pathways (reviewed in (1)). One 
prominent seasonal neuroendocrine output is the 
release of prolactin. This axis is exquisitely 
sensitive to photoperiod in all seasonally 
breeding mammals, with marked activation of 
prolactin secretion by long summer-like 
photoperiods (2). 
The pars distalis (PD) of the pituitary is thought 
to be regulated by paracrine signals from the 
pars tuberalis (PT), a melatonin receptor-rich 
tissue lying on the ventral surface of the median  
eminence (ME), and creating an interface 
between the hypothalamus and the PD (3). PT 
cells are  known to secrete an un-characterised 
low molecular weight peptide(s) (termed 
“tuberalin”), which is capable of eliciting 
prolactin secretion from distal lactotroph cells in 
culture (4-7). These studies have led to the 
proposal that melatonin acts on PT cells to elicit 
a local paracrine secretion of a prolactin-
releasing peptide. In vitro studies of seasonal 
hamster tissue has revealed that the activity of 
this secretagogue is under photoperiodic control, 
with higher levels of activity observed in PT 
tissue derived from long photoperiod (LP) 
compared to short photoperiod (SP)-housed 
animals (6). Surgically hypothalamo-pituitary 
disconnected (HPD) sheep, in which the PT has 
been disconnected from the hypothalamus, retain 
both robust photoperiodically-driven cycles of 
prolactin secretion and sensitivity to melatonin 
(8). Further, HPD sheep are also capable of 
generating long-term circannual rhythms of 
prolactin secretion when maintained in 
unchanging photoperiod conditions. This result 
suggests that this tissue may operate both as a 
seasonal calendar, responding to seasonal 
changes in the melatonin signal, and as a 
circannual oscillator (9). Collectively, these 
studies support a hypothesis that melatonin 
regulation of the seasonal prolactin axis is 
dependent upon melatonin acting on PT cells 
without input from the hypothalamic or other 
neural structures, and regulating seasonal 
prolactin secretion via a direct intra-pituitary 
paracrine mechanism.  
Here, we investigated seasonal transcriptional 
changes occurring in the PT, using RNA 
extracted from sheep kept under SP or LP and 
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collected at three time-points over the light/dark 
cycle. For whole genome transcriptome analysis 
sheep RNAs were cross-hybridised against a 
bovine 15,000 gene cDNA microarray, allowing 
comparison of relative expression at each of the 
three time points for SP and LP housed 
individuals. Of the 15,000 probes spotted on the 
array, 54 transcripts exhibited a significant, 
photoperiod-dependent alteration in expression, 
including Prnp, encoding the prion protein 
which was strongly up-regulated on SP. 153 
transcripts exhibited significantly altered 
expression associated with the light/dark 
transition and onset of melatonin secretion on 
SP. Among these, the circadian clock gene Cry1
was the most strongly displaced of all genes on 
the array, with strong up-regulation at the time 
of melatonin rise on SP. In addition to Cry1, we 
identified a small cluster of genes at this time 
point, including Kcnq5, Pbef/Nampt involved in 
insulin regulation, energy metabolism sensing 
and adipose tissue physiology, NeuroD1 and the 
hypoxia inducible factor (Hif1α), both of which 
act as bHLH transcription factors. We validated 
the arrays by Q-PCR for two of these transcripts 
(NeuroD1 and Pbef/Nampt) and confirmed 
differential expression at early night in SP. All 5 
transcripts showed strong expression in the PT 
using in situ hybridization. In order to determine 
whether these Cry1-associated transcripts were 
also directly responsive to melatonin, we tested 
acute responses of these genes following 
melatonin treatment in sheep. Four genes (Cry1, 
NeuroD1, Pbef/Nampt and Hif1α) were 
immediately and strongly induced by melatonin 
treatment.  
Our study identifies new transcriptional 
pathways and candidate genes regulated by 
photoperiod and/or at specific phases of the 
light/dark cycle in the sheep PT, and also 
identifies novel genes which are acutely 
regulated by melatonin.
Materials and Methods 
Array experiments and collection of tissue for 
validation of outcomes 
Animals and experimental design: 
Animals were castrated as lambs on the farm as 
part of normal agricultural practice and use of 
this castrate model allowed studies of seasonal 
changes in gene expression without the 
complication of altered background levels of sex 
steroids. 
Array experiments: For comparison 
using arrays, 40 male Black-face sheep were 
housed indoors from mid-winter (January 13) 
under artificial long photoperiod (LP =16 hours 
light: 8 hours dark).  At Week 14, 20 animals 
were killed at three different time points: 
Zeitgeber time (ZT) 4 (n=7), ZT12 (n=7) and 
ZT20 (n=6), where ZT0 by convention 
represents the transition from light to dark of a 
24h cycle. Two weeks later, the remaining 
cohort were switched to artificial short 
photoperiods (SP = 8 hours light: 16 hours dark) 
for 10 weeks and then killed at the same time 
points at Week 26. Dim red background lighting 
was provided throughout (<5 lux). By this 
means, the LP cohort were collected at two time 
points in the light (ZT4 and 12) and one in the 
dark (ZT20) while the SP group were culled at 
one time point in the light (ZT4) and two in the 
dark (ZT12, 20). The experimental design is 
outlined in Fig. 1. This allowed subsequent 
comparisons between photoperiods and also at 
time of lights off/melatonin rise for LP and SP 
housed animals (see below). Animals used in the 
array experiment were blood-sampled for 
prolactin determination (10 animals per 
photoperiod group) at twice weekly intervals; 
plasma was separated by centrifugation and 
stored at -20OC until assayed. Prolactin samples 
were assayed in duplicate as previously 
described (10). Intra and inter assay coefficients 
of variance were <10%. 
 Collection of tissue for validation of 
array outcomes: To provide tissues for the 
localization of candidate genes identified on the 
arrays, 12 intact male Soay sheep were kept 
under SP for 6 weeks, and 6 were culled at ZT3 
and 6 at ZT11 on SP’s (lights off at ZT8).  
For the array studies, brains were rapidly 
removed and the pars tuberalis (PT) was 
removed by microdissection, snapped frozen on 
dry ice and kept at -80°C until RNA extraction. 
For the other in situ hybridization 
determinations, brains were removed and 
hypothalamic blocks including the PT were 
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isolated by dissection and kept at -80°C until 
cryostat sectioning. All animals were killed by 
overdose of sodium pentobarbital. During the 
dark phase there was no use of accessory 
lighting and after death the animals head was 
covered prior to removal of the brain. All 
experiments were undertaken in accordance with 
the Home Office Animals (Scientific 
Procedures) Act (1986), UK, under a Project 
License held by GAL. 
 Animals used for melatonin treatment 
The experimental procedure reported in this 
study was carried out in accordance with the 
Authorization 37801 for Animal 
Experimentation and Surgery from the French 
Ministry of Agriculture. 24 adult intact female 
Ile de France sheep were used in this 
experiment. They were reared outdoors at 
Nouzilly, INRA, France and moved to an open 
indoor shed exposed to natural photoperiods 
(14.5h light: 9.5h dark) two weeks before the 
study (April 15). On May 2nd, the animals were 
exposed to continuous light over the entire 
nocturnal period in order to suppress natural 
melatonin production. At 07:30 the following 
day 12 animals were treated with two 
subcutaneous melatonin implants (Mélovine®, 
CEVA Animal Health, Libourne, France (11)) in 
the ear and the remainder received no implant, 
but had their ear punctured identically. The 
animals (4 per group) were subsequently culled 
at +1h30min, +3h30 min and +6h30 min for 
collection of PT and hypothalamic tissue. All 
animals were blood sampled 30 min after 
implant insertion, and again just prior to culling 
for determination of melatonin concentrations in 
blood plasma using a standardized 
radioimmunoassay (12). All samples were 
included in the same assay and the intra-assay 
CV was 2.7%. 
Ovine cDNA 
Ovine PT RNA (1.5μg) was reverse 
transcribed to undertake 3’- and 5’-RACE PCR 
(BD SMART RACE cDNA amplification, BD 
biosciences, Oxford, UK) to obtain ovine cDNA 
sequences for NeuroD1 and Pbef/Nampt, 
following the manufacturer recommendations. 
Gene Specific Primers (GSPs) and Nested Gene 
Specific Primers (NGSPs) were designed 
according to Mouse NeuroD1 mRNA sequence 
(NM 010894) (GSP1:5’-CAG TCA CTG TAC 
GCA CAG TGG ATT CG-3’; NGSP1:5’-GGA 
ATA GTG AAC TGA CGT GCC-3’; GSP2:5’-
GAG CGA GTC ATG AGT GCC CAG C-3’ ; 
NGSP2: 5’-GGC ACG TCA GTT TCA CTA 
TTC C-3’) and Human Pbef1 mRNA sequence 
(NM 005746) (GSP1:5’-GCC TAA TGA TGT 
GCT GCT TCC AGT TC-3’ ; NGSP1:5’-TCT 
TCA CCC CAT ATT TTC TCA CAC GC-3’). 
Amplified product were then ligated into pGEM-
T Easy (Promega, Southampton, UK) and 
selected clones were sequenced using Big Dye 
Terminator v1.1 Cycle Sequencing kits 
(Amersham, Piscataway, NJ, USA, following the 
manufacturer protocol) by the DNA sequencing 
service at the University of Manchester. 
Sequences obtained for NeuroD1 and Pbef were 
submitted to the Genebank database (Accession 
numbers DQ_82274, DQ_822275). 
A 350 to 450 bp cDNA fragment was 
sub-cloned in pGEM-T easy for NeuroD1 and 
Pbef, using 5’-ACT GCC TTT GGT AGA AAC 
AGG G-3’ or 5’-AGA TCC AAG AAG CCA 
AAG AGG-3’ respectively as forward primer 
and 5’-GCT AAG GCA ACC CCA ACA AC-3’ 
or 5’-GAA GTT AAC CAA ATG AGC AGA 
TG respectively as reverse primer. These clones 
were used to prepare standards for Q-PCR 
experiments and riboprobes for in situ
hybridizations. 
Ovine PT tRNA was reverse transcribed 
and used directly as template to clone a fragment 
of 350 to 450bp in pGEMT-easy using the 
following primers : 5’-CCA TGG TGA CCA 
CGG GT-3’and  5’-AGC TAA GAG CAT CGA 
GGG G-3’ for 18S (AF_176811); 5’-CTG CAC 
CAC CAA CTG CTT AG-3 ‘ and  5’-TG TCG 
TAC CAG GAA ATG AGC-3’ for Gapdh
(U_94889); 5’-CCC ACT CAA ATG CAA 
GAA CCT CC-3’ and 5’ - CGC TTT CTC TGA 
GCA TTC TGC A - 3’ for Hif1α (NM_174339);
5’–TGG TCT ACG CGC ACA GCA AG-3’ and  
5’-CTG CAG GTG TGC AAG GCC TT-3’ for 
Kcnq5 (XM_864552). Sequences obtained for 
Hif1α and Kcnq5 were submitted to the 
Genebank database (Accession numbers 
EU_706449 and EU_706550). Clones for 18S
and Gapdh were used to obtain Q-PCR 
standards, those obtained for Hif1α and Kcnq5 
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were used to obtain riboprobes for in situ
hybridizations. 
Quantitative PCR and in situ hybridization 
2μg of each RNA sample used in the 
microarray experiments was reverse transcribed 
for Q-PCR validation. Genomic DNA was 
removed using 1 unit  of RQ1 RNase-free DNase 
(Promega) for 30 min at 37°C, the reaction was 
stopped by adding 1μl of the DNase stop 
solution (Promega) and incubating the samples 
10 min at 65°C and the 1 min on ice. Samples 
were then processed for cDNA conversion in a 
final volume of 20μl containing 0.5μM oligo-dT 
(5’-TTT TGT ACA AGC T23-3’), 500μM each 
dNTP, 1X first-strand buffer, 10μM DTT and 
10U SuperScriptTM Reverse Transcriptase II 
(Invitrogen, Paisley, UK). The samples were 
incubated for 1 hour at 42°C and reverse 
transcriptase was inactivated by heating at 70°C 
for 15 min. Negative controls without enzyme 
were done in parallel. For quantification, 
standards were cloned as described above and 
used as template for PCR reactions with the 
cloning primers and usual PCR methods. Each 
samples was processed for Q-PCR as duplicates; 
reactions were done in 25μl final contained 5μl 
cDNA (or DEPC-treated water for negative 
control, or standard samples), 100nM TaqMan 
probe (Eurogentec, Southampton, UK), forward 
and reverse primers at 300nM each, and 1x 
qPCR MasterMix and using the following 
cycling conditions : 2 min at 50°C, 10 min at 
95°C and  40 cycles of 95°C for 15 sec and 60°C 
for 1 min. Primers and TaqMan probes were 
designed using the Primer Express 2.00 
software, sequences are shown in Table S1. Data 
were obtained through the ABI Prism 7000 SDS 
software (version 1.1, Applied Biosystems, 
Warrington, UK). Values are shown as relative 
units with the ZT4 value in LP set at 1. 
Radiolabelled sense and anti-sense ovine 
riboprobes for Cry1, Per1, NeuroD1, 
Pbef/Nampt, Rorβ, Hif1α and Kcnq5 (cloned as 
described above) were produced using a T7 or 
Sp6 polymerase as appropriate on linearised 
templates in the presence of 33P-UTP (MP 
Radiochemicals, USA). The following in situ
hybridisation procedure was previously 
described by (13). Briefly, probes were 
hybridized overnight at 60°C on coronal or 
sagital hypothalamic sheep brains cryostat 
sections (20μm thick for the validation of the 
array outcome and 18μm for the melatonin 
experiment). Hybridization signals were 
visualised on autoradiographic films (Kodak 
Biomax MR Films, Kodak, USA) after one week 
exposure at -80°C. Signal intensity was 
quantified by densitometry analysis of 
autoradiographs using the image-Pro Plus 6.0 
software (Media Cybernetics, Inc., Marlow, UK) 
on the coronal sections (4 animals per group 
except the Ctl 1h30 (n=3) in Fig.6). Relative 
optical density in the PT was then calculated for 
each group. 
Analysis of differentially expressed gene sets 
The R/Bioconductor analysis, described 
in the supplementary information, identified 
genes differentially expressed between LP/SP 
days either at ZT4, ZT12 or ZT20. In addition, a 
filter of greater than 1.3-fold difference in gene 
expression was used to limit the number of genes 
to the most biological relevant. Up-regulated 
genes show expression on LP > SP days, and 
down-regulated genes expression on LP < SP 
days. Since cDNA arrays yield relative ratio-
based data rather than absolute values, for 
purposes of subsequent descriptions, all gene 
changes are described with reference to long-day 
mRNA values (i.e. described as up or down-
regulated on long photoperiods). The design of 
the experiment allowed three gene expression 
patterns to be analysed (Table 1), namely 
photoperiodically regulated, SP early night 
regulated, and SP late night regulated.
Ontologizer (14); 
www.charite.de/ch/medgen/) was used to 
analyse differentially expressed genes for 
overrepresentation of Gene Ontology (GO) 
terms. This parent–child procedure measures 
overrepresentation conditional on annotations to 
the parent of any term, whereas previous 
approaches measure overrepresentation of each 
term in isolation. Definitions of GO terms 
(version 5.623) and gene associations were 
downloaded from the Gene Ontology website 
(15); www.geneontology.org). Human orthologs 
(Uniprot accessions) of cattle proteins were used 
for GO term analyses. The associations of GO 
terms with Uniprot accessions of human proteins 
were provided by GOA (version 1.75) (16). The 
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overrepresentation of GO terms for proteins in a 
set of differentially expressed genes was 
compared to a reference set of proteins, which 
contains all the genes expressed on the 15K 
cattle cDNA array. The parent–child-union 
option was used, which is less conservative than 
the parent–child-intersection method. The P-
values were adjusted using Westfall–Young
single-step multiple testing correction  (17). 
Pathway-Express (18);   
http://vortex.cs.wayne.edu/) was used to detect 
significant associations between differentially 
expressed genes and known pathways. In this 
method an impact factor is calculated for each 
pathway incorporating parameters such as the 
normalized fold change of the differentially 
expressed genes, the statistical significance of 
the set of pathway genes, and the topology of the 
signaling pathway. The impact factor 
corresponds to the negative logarithm of the 
global probability of having both a statistically 
significant number of differentially expressed 
genes and a large perturbation in the given 
pathway. The input to Pathway-Express was a 
set of differentially expressed genes and their 
fold changes, using the gene symbols of human 
orthologs of cattle genes. These gene sets were 
compared to the reference chip, which contains 
all the gene symbols expressed on the 15K cattle 
cDNA array. 
Potential transcription factor binding 
sites (TFBS’s) were predicted using Match/F-
Match (19) as overrepresented sites in cattle 
promoter sequences for a set of co-regulated 
genes. A Perl script takes as input a set of co-
regulated genes (“positive set”) and a set of 
genes not affected by the treatment (“negative 
set”, limited to 2000 sequences) to extract cattle 
promoter sequences for further analysis. These 
promoter sequences were downloaded using 
Biomart from Ensembl (version 48) as the 5-kb 
flanking regions of all known cattle genes. 
Match was used to detect potential TFBS’s using 
the positional weight matrices (PWM’s) from the 
Transfac database (version 12.1; a library of 846 
PWM’s for vertebrate transcription factors 
(TF’s)) constructed from collections of known 
binding sites for given TF or TF family. A built-
in matrix profile with cut-off values adjusted to 
minimize the sum of false positive and false 
negative errors 
(vertebrate_non_redundant_minFP) was used in 
the detection of TFBS’s. F-Match was then used 
with default parameters to detect 
overrepresented TFBS’s. Raw probability values 
were extracted and used as input to Qvalue (20) 
to calculate false discovery rates (FDR). 
General statistical analysis 
Results are shown as means +/- SEM. 
After ANOVA analysis the Bonferroni test was 
applied to analyze differences between groups. 
Differences were considered significant at 
P<0.05. 
Results 
Photoperiod response in the animals used in the 
array analysis 
 Plasma prolactin concentrations were 
approximately 50-fold higher in the sheep culled 
across the three time points (ZT4, ZT12 and 
ZT20) under LP compared to the cohort culled 
under SP (Fig. 1). Thus the PT tissues used in 
the array analysis derived from animals in 
seasonally distinct physiological states 
Gene transcriptome analysis of the ovine PT 
The use of a bovine cDNA microarray 
relied on cross-species hybridisation between 
two closely related ungulates with ~97% 
sequence identity (21). The nature of the array 
comparison did not permit absolute values for 
altered expression to be defined since LP and SP 
samples were co-hybridized to the array. Thus, a 
transcript may appear as being up-regulated on 
LP, but equally the same outcome could occur if 
it were strongly suppressed by SP. By 
convention, we describe our results below in 
terms of relative expression in LP-housed sheep, 
so that transcripts exhibiting relatively greater 
expression in LP-derived samples are defined as 
being relatively up-regulated. Single channel 
analysis revealed that ~55% of the transcripts on 
the array were expressed in the sheep PT. The 
design of the experiment allowed three gene 
expression patterns to be analysed, namely genes 
exhibiting altered expression at all 3 time points 
(designated as “photoperiodically” regulated), 
genes exhibiting altered expression at ZT12 
(designated SP early night) but not at ZT4 and 
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genes showing altered expression at ZT20 only 
(designated SP late night; Table 1). 
Photoperiodic genes 
 Of the transcripts exhibiting 
significantly altered expression at all three time 
points a total of 36 transcripts were relatively up-
regulated and 18 down-regulated (Table S2). 
These included up-regulation of a CREB-
regulated transcription co-activator 1 gene 
(CRTC1), represented by two different probes 
both of which were significantly displaced on 
the array, and a methyl transferase gene 
(PMRT5). The gene encoding the prion protein 
(PRNP) was the most strongly displaced 
transcript in the LP-repressed cluster. The 
Pathway-Express analysis revealed over-
representation of 15 pathways including 
olfactory transduction, MAPK and PPAR 
signalling pathways in the LP repressed gene set 
(Table 2). No significant over represented 
pathway was found in the LP induced set. 
Ontologizer analysis revealed significant over-
representation of GO terms for carbohydrate and 
lipopolysaccharide processes for LP-repressed 
genes (Fig. S2). There was no detectable 
significant over-representation of GO terms in 
the LP induced group of genes. Analysis of 
putative transcription factor binding sites within 
each gene set included sites for homeobox, 
paired homeobox, bZIP and forkhead 
transcription factors (Table 3). 
Genes changing at ZT12 (SP early night) 
 A total of 147 transcripts exhibited 
altered expression at ZT12; with 28 up-regulated 
and 125 down-regulated at this time point (Table 
S3). In the later group, the focal gene Cry1
exhibited the greatest differential expression for 
any gene on the array (3.38 fold increase on SP). 
The activation of Cry1 predictably occurred 
when ZT12 coincided with darkness under SP 
and light under LP. Genes exhibiting gene 
expression patterns similar to Cry1 included a 
general transcription factor (Gtf2a1), the 
voltage-gated potassium channel Kcnq5, 
NeuroD1 (an E-box regulated bHLH 
transcription factor), Pbef (Visfatin/Nampt) (a 
key regulator of the NAD/NADH salvage 
pathway) and the hypoxia-induced transcription 
factor 1 alpha (Hif1α, a close relative of the 
circadian clock gene Bmal1) (Table S3; Fig. 2).
Both Hif1α and NeuroD1 were represented twice 
on the array by different regions of the cDNA, 
and both clones exhibited significant and similar 
magnitude changes, providing additional 
validation. Expression of MEF2A, a transcription 
factor, was also increased in SP at ZT12, 
consistent with a subsequent analysis identifying 
over represented transcription factor binding 
sites (see below). SP early night repressed genes 
(28 transcripts), included two genes involved in 
circadian regulation (the kinase GSK3β and the 
nuclear hormone receptor Rorβ). Analysis of 
over-representation of pathways within each 
gene set included pathways involved in cytokine 
- cytokine receptor interaction (over-represented 
in the SP early night (ZT12) repressed gene set) 
and pathways involved in circadian rhythm 
(over-represented in the SP early night induced 
gene set; Table 2). Ontologizer analysis revealed 
significant over-representation of GO terms for 
immune function for SP early night repressed 
genes (Fig. S2). There was no significant over-
representation for genes up-regulated on SP’s at 
ZT12. Analysis of putative transcription factor 
binding sites within each gene set included sites 
for bHLH-ZIP, bZIP, forkhead and paired 
homeobox factors for genes down-regulated at 
ZT12 on SP’s, and bZIP, forkhead, paired 
homeobox, POU and MADS (represented by 
MEF2, myocyte-specific enhancer factor) for the 
SP early night induced gene set (Table 3). 
Genes changing at ZT20 (SP late night) 
  Genes showing significant changes at 
ZT20 are listed in Table S4. A total of 11 
transcripts were significantly up-regulated on LP 
at this time point (SP late night repressed), and 
35 down-regulated (SP late night induced). The 
circadian clock gene Bmal1 (ARNTL) was one of 
the most strongly down-regulated genes (SP-late 
night induced), and was co-expressed with the 
IgG receptor precursor FCGRT, a 
glutamate/aspartate transporter (SLC1A3) and 
QK1, an RNA-binding protein. Analysis of over-
representation of pathways included ErbB and 
Notch signaling pathways, circadian rhythm and 
olfactory transduction in the SP late night 
induced gene set (Table 2) while no significant 
over-represented pathways was found in the 
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other gene set. GO term enrichment within this 
SP late-night induced genes included genes 
involved in oxydoreductase activity and 
organelle and endoplasmic reticulum membrane.  
Identification of a Cry1-associated co-
expression gene cluster 
The distribution of relative expression changes 
for ZT12 vs. ZT4 (dark vs. light) and ZT12 vs. 
ZT20 (early night vs. late night) under SP is 
shown in Fig. 2. At both time comparisons, the 
target gene Cry1 was the most strongly displaced 
gene of the 15K transcripts detected using the 
array. For comparison, NeuroD1 and c9orf77
(both represented by two transcripts on the 
array) and Pbef /Nampt and Gtf2a1 are also 
significantly displaced with strong down-
regulation at ZT12 and closely associated with 
the Cry1 cluster. For subsequent analyses we 
selected Pbef /Nampt, NeuroD1, to confirm 
time-of-day changes in expression and 
regulation in the PT, and also Rorβ, 
(significantly up-regulated at ZT12 on LP’s) as 
an example of a gene expressed at an opposite 
phase.  
Q-PCR and in situ hybridization comparisons
 The regulation of NeuroD1 and 
Pbef/Nampt mRNA in the PT was confirmed 
using quantitative PCR of PT tissue RNA (Fig. 
3). In confirmation of the array data, both 
NeuroD1 and Pbef were significantly up-
regulated at ZT12 in SP compared to LP,  as 
revealed in the microarray analysis (p<0.05) and 
values were higher at SP’s at ZT12 compared to 
SP’s at ZT4 for both NeuroD1 and Pbef/Nampt 
(2.69 compared to 5.25 and 1.45 compared to 
2.25 respectively). Control genes (18S and 
GAPDH) did not reveal significantly altered 
expression in either photoperiod with no 
significant variation between each condition 
(ranging from 1 to 1.40 and 0.97 to 1.23 
respectively). Radioactive in situ hybridization 
results for sagital and coronal hypothalamic 
sections collected from sheep kept under SP and 
culled at ZT3 and ZT11 are shown in Fig. 4. As 
expected, Cry1 exhibited markedly altered 
expression, with low levels at ZT3 (day) and 
strong induction at ZT11 (night), while Per1
revealed an opposite pattern of expression with 
elevated expression at ZT3 (Fig. 4 A, B). Both 
Pbef/Nampt and NeuroD1 were strongly 
expressed in the PT (Figs. 4 C, D), and the 
quantification of the PT revealed that there was 
significant up-regulation at ZT11 for both 
transcripts (Fig. 4 E, F). For NeuroD1, the 
pattern of expression was very similar to Cry1. 
Pbef/Nampt was also strongly expressed in the 
PT, but a signal was also observed in the median 
eminence (ME) (Fig. 5C). In contrast to the PT, 
quantification of relative changes in expression 
from ZT3 to ZT11 revealed no significant 
alterations in Pbef/Nampt
 expression in the ME. 
Rorβ expression in the PT showed a significant 
down regulation at ZT11 on coronal sections as 
assessed by in situ hybridisation (Fig. 5).  
Response of Cry1-assciated genes to acute 
melatonin treatment  
 Blood samples from animals treated 
with melatonin implants (Mélovine®) rose to 
131pg/ml melatonin within 30 min of treatment, 
and were 398 (+/-215), 142 (+/-33) and 301 (+/-
156) pg/ml at 1h 30min, 3h 30min and 6h 30min 
respectively. Un-treated animals had levels of <4 
pg/ml. Typical reference samples from animals 
sampled under natural ambient daytime lighting 
are <4pg/ml and 260 pg/ml for mid-night. We 
quantified by in situ hybridization genes 
showing a similar change in expression to Cry1
at ZT12 (Cry1, Kcnq5, NeuroD1, Pbef//Nampt
and Hif1α; Table S3; Fig. 2). This revealed 
strong PT expression for all 5 transcripts (Fig. 
6). Melatonin treatment resulted in a significant 
increase in expression for all but Kcnq5, with a 
peak at 3h30min and subsequent decline by 
6h30min in all 4 cases. At this latter time point, 
relative expression levels were still 
approximately twice that of un-treated control 
animals, with the exception of Hif1α, which had 
returned to a similar level to that of controls. 
With the exception of Nampt, expression was 
confined to the PT for all transcripts.   
Discussion 
Use of cDNA array to identify candidate genes 
and pathways 
In our study, exposure of sheep to LP resulted in 
a robust activation of prolactin secretion over a 
two-month period, which was reversed by 
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exposure to SP consistent with earlier 
publications on this species (8), providing a key 
physiological endpoint validating subsequent 
analyses of the PT for transcriptome analysis. 
The array we used provided extensive genome 
coverage (~50%), and because sheep PT tissue 
provided sufficient material from individual 
animals to be run on a single array slide, errors 
associated with RNA pooling were reduced and 
confidence in the statistical power of the data 
greatly increased. Our data presented here 
demonstrates that we are able to use a bovine-
derived cDNA array to identify altered 
expression in ovine genes from the PT. 
Specifically, the sequence homology with bovine 
genes was more than 97%, allowing a high level 
of cross-hybridization (further details in the 
supplementary information). Further, candidate 
genes were confirmed by Q-PCR and in situ
hybridization and in all cases, we identified the 
correct ovine homologue expressed within the 
PT (i.e. there were no false positive). We 
identified 53 to 65% of genes on the array which 
were expressed in the PT, and this is within the 
typical range of expression observed in a 
particular tissue (22). Thus, use of this well 
characterised cDNA array and sheep PT model 
offers an excellent insight into global 
transcriptome changes at a melatonin target site. 
Genes exhibiting “time-of-day” alteration in 
expression 
Of all of the genes exhibiting differential 
expression on the array, the circadian clock 
regulator Cry1 exhibited the greatest relative 
expression change. The relative phasing of 
arrayed Cry1 and Bmal1  clock genes revealed 
that Cry1 was strongly down regulated at ZT12 
(SP early night induced) with Bmal1  induced at 
late night (ZT20) in SP. Our in situ hybridisation 
studies also confirmed that strong expression of 
Per1 and Cry1 were anchored to dawn and dusk 
respectively, matching the putative offset and 
onset of the melatonin signal. Collectively, these 
data are in accord with previous studies of clock 
gene expression in the PT of sheep and seasonal 
rodents which show strong phasic expression 
associated with the rise and fall of the daily 
melatonin signal (23, 24). Other clock transcripts 
such as Hif1α/MOP1, GSK3β and Rorβ were 
also identified as significantly altered in 
expression on the array, and the subsequent 
pathway analysis revealed a significant general 
over-representation of circadian genes within 
this data set.  
Our Q-PCR and in situ hybridisation validation 
revealed that Pbef/Nampt, and NeuroD1
exhibited specific expression in the sheep PT 
and were strongly expressed at ZT11 (night 
phase) compared to ZT3 (light phase) in SP-
housed animals, matching array outcomes. In 
contrast, the Rorβ in situ hybridisation revealed 
down regulation at ZT11, also consistent with 
the array data. The expression pattern of 
NeuroD1 and Rorβ in the PT very closely 
matched that of Cry1. In contrast, Pbef/Nampt
exhibited lower levels of expression in the ME, 
but expression in this structure did not alter with 
time of day. NeuroD1 (Neurogenic 
differentiation factor 1) is a basic helix-loop-
helix transcription factor that binds E-boxes after 
dimerization with other HLH domain containing 
proteins (25). It is widely expressed in the 
vertebrate developing central nervous system 
and is also expressed in specific areas in the 
adult brain (cerebellum, hippocampus, PVN and 
DMN (26-28)). NeuroD1 is a key transcription 
factor involved in corticotroph regulation and 
pancreatic beta-cell differentiation (29, 30) and 
the knock-out in mice is lethal (30). In the adult, 
it is strongly expressed in the endocrine cells of 
pancreas, intestine and pituitary and in these 
structures is known to regulate insulin, secretin 
and POMC respectively (25, 26, 31, 32).
NeuroD1 thus plays a central role in both the 
development and subsequent regulation of 
multiple endocrine tissues, and our data now 
suggest that it may play an important additional 
role in the PT.
Pbef (pre-B-cell colony enhancing factor) was 
first isolated from peripheral blood lymphocytes 
and was characterised as a growth factor of B 
cells precursors by facilitating development of 
early stage B cells (33). As reviewed by Revollo 
et al (34), Pbef is also known as Nampt
(nicotinamide phosphoribosyltransferase), as it 
acts as a key rate limiting enzyme in the NAD 
salvage cycle of the cell, and more recently as 
visfatin. Pbef/Nampt has been associated with 
the development of obesity and insulin resistance 
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and type 2 diabetes (35, 36) but it is currently 
unclear whether it is directly involved in the 
development of insulin resistance, or indirectly 
as a marker of inflammatory state (37). The gene 
is strongly expressed in a circadian rhythmical 
fashion in adipose tissue in mice , and, as we 
have observed in the PT,  strongly co-associated 
with Cry1 (38).  Our study shows for the first 
time that Pbef/Nampt is strongly and 
rhythmically expressed in the PT.  
A number of studies have linked the NAD cycle 
of the cell to circadian clock function. For 
instance, investigations by McKnight and co-
workers have shown close links between energy 
sensing and the NAD cycle and the regulation of 
circadian clock genes Clock and NPAS2 in the 
central nervous system (CNS) (39, 40). A key 
transcriptional regulator of Pbef/Nampt is Hif1α
a close relative of the circadian clock gene 
Bmal1 (41, 42) and we observed that HIF1α was 
also strongly induced on our array in early night, 
at the same time point as Pbef/Nampt (i.e. Cry1-
associated). Both Pbef/Nampt and Hif1α are 
strongly induced both in conditions of hypoxia 
and cell stress (43). HIF1α protein cooperates 
with bHLH circadian transcription factors such 
as CLOCK and BMAL1 allowing cross-talks 
between hypoxic and circadian pathways (44, 
45). Through its action on the NAD/NADH 
cycle Pbef/Nampt is the key enzymatic regulator 
of a sirtuin gene (Sirt1) coding for a NAD-
dependent deacetylase with widespread actions 
on cellular senescence and ageing (reviewed in 
(46)). Pbef/Nampt is thus ideally poised to serve 
both as a link between circadian timing 
complexes and, via its action on the 
NAD/NADH cycle, as an energy metabolism 
sensor, regulating through its action on Sirt1 
both genomic (i.e. histone modification) and 
non-genomic pathways (47).  
Melatonin regulation of PT gene expression
Recent studies have shown that circadian clock 
genes are rhythmically expressed in the PT of 
seasonally breeding mammals, and also in 
strains of mice which secrete melatonin (23, 24, 
48-51). In seasonal rodents and sheep the 
circadian clock gene Per1 is expressed in the PT 
and is activated in the early morning in direct 
response to the decline in the nocturnal 
melatonin signal and altered cAMP signalling. In 
contrast, the clock gene Cry1 is rhythmically 
expressed in the dark phase, co-incident with the 
onset of pineal melatonin secretion, and in both 
sheep and hamsters melatonin treatment has 
been shown to directly induce Cry1 expression 
in the PT irrespective of the phase of the 
light/dark cycle (52). PER and CRY are key 
components of the feedback loop controlling the 
master clock in the suprachiasmatic nucleus 
(SCN). These two proteins are co-incidentally 
expressed within the SCN and heterodimerise to 
rhythmically modulate circadian gene 
transcription via E-box motifs on target genes 
(53). Studies of seasonally breeding sheep have 
revealed that in contrast to the SCN, within the 
PT Per1 and Cry1 mRNA track the offset and 
onset respectively of the melatonin signal such 
that seasonal changes in the duration of the 
melatonin signal are reflected in an altered phase 
relationship of these two core clock components. 
From this, it has been proposed that melatonin-
regulated seasonal changes in the phasing of the 
PER/CRY interval may operate as an internal 
co-incidence detector, providing a genetic 
mechanism based on circadian clock genes for 
the PT to decode the seasonal photoperiodic 
melatonin signal (9, 54-56) and drive down-
stream molecular events via E-box mediated 
transcription. To date, Cry1 is the only gene 
known to be regulated melatonin. 
Our study has confirmed earlier studies which 
demonstrate that Cry1 is an acutely melatonin-
regulated gene and now identifies additional 
“Cry1-associated” genes in the array. 
Remarkably, several of these (Pbef/Nampt, 
Hif1α, and NeuroD1) are, like Cry1, also 
strongly induced by melatonin, and over the 
same time course. These data now suggest that 
in addition to Cry1, melatonin may regulate a 
number of down-stream molecular pathways in 
the PT, although we have no insight yet as to 
whether these novel melatonin-regulated genes 
contribute to the photoperiodic response, or 
simply act as a marker of phase for the onset of 
melatonin secretion. Little is known of how 
melatonin may induce such rapid changes in 
gene expression in a target tissue. Classically, 
this hormone is thought to act by inhibiting 
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cAMP signalling pathways (57). The speed of 
transcriptional response in the PT would mitigate 
against regulation by de-novo production of an 
intermediate factor, and it is possible that these 
responses represent direct transcriptional 
activation by a melatonin-regulated signalling 
system. Cry1 and NeuroD1 are known to be 
regulated in a circadian manner by E-box acting 
transcription factors, and we have recently 
identified a putative E-box site within the 
presumptive promoter of Nampt (Kim, Dupré, 
unpublished). However, HIF1a is an E-box 
acting transcription factor and is not known to be 
regulated itself via an E-box. Since a large 
number of genes were shown to be significantly 
expressed on SP at ZT12 and several/many of 
these may also be melatonin regulated, 
identification of further melatonin regulated 
clusters may allow us to define unique 
transcription factor binding sites within the 
regulatory elements of these genes, and thus 
candidate proteins for the immediate down-
stream pathways on which melatonin acts. 
Phenotypes of the PT 
To date, no studies have been undertaken of the 
transcriptome of the mammalian PT and 
relatively little is known of the genetic 
phenotype of these cells. Melatonin receptors are 
strongly expressed in the PT of seasonal 
mammals, and studies of Siberian hamsters have 
revealed that PT secretory granules are more 
numerous in animals housed under LP (58). The 
mammalian PT contains three different main cell 
types, a follicular cell (reviewed in (59, 60),  
pars distalis (PD) cells of gonadotroph origin 
(61) which have migrated from the PD to the PT 
and a third cell type which expresses the  beta-
subunit for TSH and the common alpha 
glycoprotein hormone subunit (αGSU). These 
latter cells are known to co-localise with the 
melatonin receptor in the rat and European 
hamster (62, 63). In these TSHβ positive cells, 
levels of immuno-staining are significantly 
reduced under short photoperiods and are also 
sensitive to treatment with melatonin or 
pinealectomy (64, 65). All three cell types are 
included in any PT dissection; in addition, it is 
impossible to avoid inclusion of some material 
from the ME, including GnRH and other nerve 
terminals and associated glial cells. Therefore, 
the tissue screened is heterogeneous and not 
confined solely to melatonin-receptor expressing 
cells. A remarkable feature of our data is that 
with the exception of Nampt (which reveals 
weak ME expression as well as PT), all novel PT 
transcripts identified from the array revealed 
strong expression by in situ hybridization to be 
specific to the PT, validating this combined 
approach as a means for detecting novel PT 
pathways. 
Genes exhibiting photoperiodic alteration in 
expression 
By comparing three different time points over 
the light dark cycle for LP or SP housed animals 
we were able to identify differentially expressed 
genes which exhibited a consistent alteration in 
expression at all three time-points 
(“photoperiodic” genes) or were significantly 
altered in expression at a specific phase (“time-
of-day” regulated genes). Clearly, genes in this 
latter category may also be “photoperiodic” if 
their general waveform of expression over the 
24h cycle is sculpted by photoperiod, but with 
only three time points assessed, we have adopted 
the conservative classification of these genes as 
“time-of-day” regulated.  Generally, our data 
revealed that relatively few transcripts exhibited 
significant alterations in expression (of the order 
of <1%). Within the photoperiodic gene-set the 
most strongly altered transcript encoded the 
prion protein (PRNP). Prion proteins are now 
recognised as serving important biological 
functions in both the mammalian CNS and 
lymphoid tissue (66). Within the CNS, the 
endogenous prion protein is important in neural 
development, synaptic transmission and neurite 
outgrowth, probably by binding to the neural cell 
adhesion molecule (N-CAM) as a signalling 
receptor (reviewed in (67). mRNA levels for 
prion proteins have been shown to be highly 
rhythmic both in the SCN and throughout the 
forebrain of rats, and in mice severe disruption 
of circadian activity and sleep-wake cycles is 
observed in prion protein-deficient transgenic 
mice (68). Our data suggest that the prion 
protein may serve an important role in this 
melatonin target tissue.  
We also observed that the potassium channel 
coded by Kcnq5, not previously identified as 
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being expressed in the PT, was also strongly LP-
repressed. A different clone of the same gene 
was also detected in the SP early night induced 
gene set, implying that this gene may fall into 
the category of a transcript in which expression 
over the day is regulated by photoperiod. Kcnq5
was only recently discovered and exhibits a 
strong expression specifically within the CNS 
(69). Recent studies have shown that Kcnq5 is 
strongly expressed in the arcuate nucleus where 
it co-localises to NPY and POMC neurones (70). 
Regulation of the Kcnq family of genes are also 
known to be important for the regulation of 
neural plasticity in the hippocampus (71). Thus, 
Photoperiod-responsive expression of Prnp and 
Kcnq5, two transcripts implicated in cellular 
communication and plasticity suggests that such 
processes may play an important role in the PT 
of a seasonal mammal. A number of genes 
exhibiting significant up-regulation on LP’s are 
associated with histone and non-histone protein 
regulation, including two methyl-transferases 
(SUV39H2; PRMT5).  
Homologous structures in birds 
A recent paper on Japanese quail has used 
heterologous chicken arrays to reveal key 
photoperiodic changes in the basal hypothalamus 
and PT (72). In this study, the authors defined 
transcript changes over the first two days 
following an extreme shift from short (4h light) 
to long (20h light) photoperiods. In quail, this 
results in a significant rise in luteinising 
hormone (LH) by the end of the first long day. 
Using arrays, Nakao et al (72) were able to 
detect two genes (Tshβ and Eya3) which were 
elevated at the end of the light phase of the first 
long day in the avian PT, and which thus may 
act as a signal to the neuroendocrine system of 
photoperiodic activation. Subsequent studies by 
this group also revealed that TSHβ acted on 
ependymal cells to induce expression of 
Deiodinase 2 (Dio2), a thyroid converting 
enzyme known to be critical to the regulation of 
the hypothalamic reproductive response in birds 
and mammals (73). Up-regulation of Dio2 was 
also associated with a larger number of 
transcripts showing altered expression in the 
hypothalamus on Day 2. This study therefore 
indicates the central importance of the PT to 
photoperiodic responsiveness in birds, and also 
demonstrates that photoperiodic activation is 
associated with synchronized waves of gene 
expression which follow a strict temporal 
pattern. TSHβ and the common sub-unit (αGSU) 
as well as Eya3 were arrayed as transcripts on 
the cattle microarrays we used. However, none 
of these genes showed significantly altered 
expression at either time of day or photoperiod. 
Our current study was based on a comparison of 
transcript changes in the PT following chronic 
(14 weeks) exposure to photoperiods and it is 
possible that altered TSH signaling represents 
earlier events in the photoperiodic response.  
Using in situ hybridization, a recent study of 
sheep has also failed to identify significant 
changes in TSH expression on Day 1 of LP 
exposure in the sheep PT, although in this study 
the authors collected samples in the early light 
phase, rather than later in the day when 
expression might be expected to be elevated 
(74). It is however highly likely that birds and 
mammals use a similar pathway and mechanism, 
as this recent study (74) has shown that altered 
Dio2 expression occurs in ovine ependymal 
cells, and that these cells are responsive to TSH, 
as in the study of Japanese quail. It is possible 
that our own study and others have missed the 
activation of TSH by sampling at the wrong time 
of day, or that in sheep the latency of response to 
LP differs from birds. These issues can only be 
addressed by additional studies over a wider 
range of time points. While further resolution of 
the identity of common pathways used by birds 
and mammals must await more extensive 
studies, it is likely that the photoperiodic 
response involves a complex series of gene 
expression changes, from the initial acute 
responses to the chronic changes detected here 
following many weeks to months (reviewed in 
75).
In summary, we have identified novel PT-
expressed transcripts in the sheep, which reveal 
significant time-of-day alteration in expression. 
Several of these genes we now show to be 
directly regulated by melatonin. Identification of 
the pathways on which these genes act and the 
manner in which they are regulated, will offer 
key insight into how this critical melatonin target 
site translates a seasonally variant melatonin 
signal into a neuroendocrine output. 
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Table 1: Definition of photoperiodic expression gene sets. 
Significant: expression differs (either up or down-regulated) between LP/SP days 
Not significant: expression equal on LP/SP days. 
Table 2: Pathway analysis 
Over representation of pathways within gene sets 
Gene set Pathway Name 
Impact 
Factor p-value 
gamma 
p-value 
Unique 
Pathway-
id 
mTOR signaling pathway 3,15 0,0431 0,179 1:04150 SP early night 
induced TGF-beta signaling pathway 3,15 0,0431 0,179 1:04350 
Cytokine-cytokine receptor interaction 5,94 0,0026 0,018 1:04060 
Neuroactive ligand-receptor interaction 3,80 0,0225 0,108 1:04080 
Complement and coagulation cascades 3,07 0,0464 0,189 1:04610 
Jak-STAT signaling pathway 3,02 0,0487 0,196 1:04630 
Type I diabetes mellitus 2,96 0,0520 0,206 1:04940 
SP early night 
repressed 
Cell adhesion molecules (CAMs) 2,88 0,0561 0,218 1:04514 
ErbB signaling pathway 5,038 0,00649 0,039 1:04012 
Notch signaling pathway 4,517 0,01092 0,060 1:04330
Regulation of actin cytoskeleton 4,484 0,01129 0,062 1:04810 
Focal adhesion 3,023 0,04864 0,196 1:04510 
Circadian rhythm 2,799 0,06088 0,231 1:04710 
SP late night 
induced 
Olfactory transduction 2,799 0,06088 0,231 1:04740 
SP late night 
repressed PPAR signaling pathway 3,713 0,0244 0,115 1:03320 
LP repressed Olfactory transduction 3,425 0,03254 0,144 1:04740 
LP induced Insulin signaling pathway 3,57 0,02815 0,129 1:04910 
Gene set ZT4 ZT12 ZT20 
Early Not 
Significant 
Significant Any 
Late Not 
Significant 
Not 
Significant 
Significant 
Photoperiodic Significant Significant Significant 
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Table 3: Transcription factor binding sites 
Over representation of transcription factor binding sites within each gene set. 
Class Name Matrix ratio 
q 
value  Class Name Matrix ratio 
q 
value 
bHLH Hand1 M00222 1,40 0,081  bHLH-ZIP USF M00796 1,70 0,390 
AP-4 M00005 1,46 0,108  bZIP C M00622 1,80 0,397 bHLH-ZIP 
Spz1 M00446 1,29 0,006  CC PPARgamma M00515 2,09 0,390 
AP-2 M00189 1,35 0,010  HOXA5 M00023 1,51 0,397 bHSH 
AP-2 M00915 1,19 0,108  
SP late 
night 
repressed 
homeo 
CDP M00102 1,29 0,397 
bZIP CHOP M00249 1,63 0,108  bHLH Tal-1beta M00065 1,76 0,170 
ER M00191 1,53 0,103  CC PPARgamma M00515 1,33 0,149 
PPARalpha M00518 1,34 0,067  fork head FOXJ2 M00423 1,28 0,149 CC 
VDR M00444 1,25 0,108  CDP M00102 3,49 0,113 
Sp3 M00665 1,86 0,067  TGIF M00418 3,10 0,149 
ZF5 M00333 1,27 0,000  
homeo 
Crx M00623 2,12 0,054 CH 
Zic2 M00449 1,10 0,108  HSF HSF1 M00146 5,01 0,054 
fork head FOX factors M00809 1,37 0,081  NK-2 Nkx2-5 M00241 1,21 0,149 
paired Pax-5 M00144 1,16 0,067  paired-homeo Pax-4 M00380 1,33 0,170 
Pax-3 M00327 1,37 0,108  Tst-1 M00133 1,51 0,054 paired-
homeo Pax-4 M00378 1,15 0,081  
POU 
oct-04 M01124 1,24 0,149 
POU POU3F2 M00463 1,40 0,108  
SP late 
night 
induced 
Rel NF-kappaB M00774 3,82 0,149 
SP early 
night 
repressed 
runt PEBP M00984 1,53 0,108  CC VDR M00966 1,30 0,268 
ARID MRF-2 M00454 1,23 0,029  KAISO M01119 3,12 0,203 
bZIP C M00622 1,27 0,013  
CH 
Egr-1 M00243 1,62 0,268 
GATA-X M00203 1,25 0,013  
LP 
induced 
homeo CDP M00102 3,06 0,203 CC 
GATA-4 M00632 1,20 0,054  bZIP MAF M00983 3,16 0,209 
YY1 M00793 1,55 0,008  fork head FOXJ2 M00423 1,66 0,046 
PLZF M01075 1,42 0,050  Crx M00623 2,27 0,156 CH 
ZF5 M00333 1,24 0,011  
homeo 
MEIS1B M00421 2,12 0,156 
fork head FOXJ2 M00423 1,50 0,003  paired-homeo Pax-4 M00377 1,35 0,167 
SRY M00160 1,38 0,035  POU3F2 M00463 2,17 0,209 HMG 
SOX9 M00410 1,25 0,064  POU3F2 M00464 1,28 0,209 
Cart-1 M00416 1,61 0,000  Tst-1 M00133 1,55 0,029 
IPF1 M00436 1,40 0,006  
POU 
Oct-1 M00137 1,46 0,096 
CDP M00102 1,28 0,003  
LP 
repressed 
trp v-Myb M00227 3,73 0,156 
HOXA5 M00023 1,23 0,000        
Xvent-1 M00445 1,19 0,000  
homeo 
Ncx M00484 1,11 0,035  
MADS MEF-2 M00232 1,83 0,020  
NK-2 Nkx2-5 M00241 1,36 0,002  
Pax-6 M00097 1,72 0,043  
Pax-4 M00377 1,52 0,000  paired-homeo 
Pax-4 M00380 1,15 0,064  
oct-04 M01125 1,95 0,005  
oct-04 M01124 1,64 0,005  
POU3F2 M00464 1,86 0,013  
Octamer M00795 1,35 0,009  
oct-01 M00248 1,32 0,063  
oct-01 M00137 1,20 0,001  
oct-01 M00136 1,15 0,064  
Tst-1 M00133 1,20 0,000  
POU 
POU3F2 M00463 1,15 0,005  
SP early 
night 
induced 
RING RUSH-1alpha M01107 1,37 0,026  
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Figure legends 
Figure 1: Blood prolactin concentration in sheep kept under long (LP) and short photoperiod (DP)  
Animals were placed under long photoperiod (LP: 16 hours light/8 hours dark) for 14 weeks, half of the 
cohort was culled throughout the light dark cycle at 3 different Zeitgeber (ZT) times (ZT4, ZT12 and 
ZT20) and 2 weeks later (dashed line), the remaining animals were transferred to short photoperiod (SP: 8 
hours light/16 hours dark) for a further 10 weeks. After 10 weeks animals were culled throughout the light 
dark cycle at the same time points (ZT4, ZT12 and ZT20). Insert indicates the times of cull for each 
photoperiod treatment. 
Figure 2: Characterisation of a cry1 co-expression gene cluster induced at ZT12 under short photoperiod 
Scatter plots showing Log2 values of the fold change SP/LP for each clone at ZT4 vs. ZT12 (A) and ZT20 
vs. ZT12 (B). Cry1 shows the strongest down-regulation at ZT12 on both scatter plots together with 
c9Orf77, NeuroD1, Pbef/Nampt and GTF2A1.
Figure 3: Validation of photoperiodic expression of NeuroD1 and Pbef/nampt in the PT. 
Relative expression of ovine NeuroD1 (A), Pbef/nampt (B), 18S (C) and Gapdh (D) mRNA by 
quantitative PCR. The results confirm the microarray data showing a strong down-regulation of NeuroD1
and Pbef in LP compared to SP at ZT12 in the sheep PT. Data are shown as relative to the ZT4 value in 
LP set at 1. Statistical significance was set at *p<0.05, **p<0.01, ***p<0.001 using one-way ANOVA 
followed by Bonferroni post-hoc test. 
Figure 4: In situ hybridization and quantification of NeuroD1 and Pbef/Nampt mRNA expression in the 
PT of SP-housed sheep 
Representative expression of Cry1 (A), Per1 (B), Pbef/nampt (C) and NeuroD1 (D) in the sheep 
hypothalamus at the level of the PT, on sagital and coronal 20μM cryostat sections at ZT3 and ZT11.  
NeuroD1 (E) and Pbef/Nampt (F) are specifically up-regulated in the sheep PT in the dark phase (ZT11) 
under SP. Scale bar: 1mm. Statistical significance was set at *p<0.05, **p<0.01, ***p<0.001 using one-
way ANOVA followed by Bonferroni post-hoc test. 
Figure 5: In situ hybridization and quantification of Rorβ mRNA expression in the PT of SP-housed 
sheep. 
Representative expression of Rorβ (A), in the sheep hypothalamus at the level of the PT, on coronal 20μM 
cryostat sections at ZT3 and ZT11 
Rorβ (B) shows a significant down-regulation in the sheep PT in the dark phase (ZT11) under SP. Scale 
bar: 1mm. Statistical significance was set at *p<0.05, **p<0.01, ***p<0.001 using one-way ANOVA 
followed by Bonferroni post-hoc test. 
Figure 6: In situ hybridization and quantification of Cry1, Kcnq5, NeuroD1, Pbef/Nampt and Hif1α
mRNA expression in the PT sheep treated or not with melatonin 
Representative expression of Cry1 (A), Kcnq5 (B), NeuroD1 (C), Pbef/nampt (D) and Hif1α  (E), in the 
sheep hypothalamus at the level of the PT, on coronal 20μM cryostat sections after 1h30, 3h30 or 6h30 on 
melatonin treated (Mel) or untreated animals (Ctl). Cry1 (A), NeuroD1 (C), Pbef/nampt (D) and Hif1α
(E) show a significant up-regulation upon melatonin treatment (black bars) in the sheep PT. Kcnq5 (B) 
doesn’t show any significant change in treated animals (black bars) compared to untreated animals (white 
bars). Statistical significance was set at *p<0.05, **p<0.01, ***p<0.001 using one-way ANOVA followed 
by Bonferroni post-hoc test. 
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